Cancer-promoting protein also helps engineered immune cells fight tumors in lab tests
Colorectal cancer has become the leading cause of cancer-related death for people under 50. Its most common forms generally aren't treatable, either through conventional means like chemotherapy or newer immunotherapy drugs.
Read original article on Medical Xpress - latest medical and health news stories →Related news
-
Ebola vaccine induces T cell cross-reactivity against Bundibugyo virus in humans
-
Common leukemia mutation derails protein positioning during cell division, study reveals
-
What happens when brain tumors return? International study tracks genetic changes behind recurring cancers
-
Insights about cachexia, one of cancer's most common complications, hiding in routine patient data
-
Most patients won't endorse AI medical responses without a clinician's review, study finds
-
Herpes 'remedies' sold on Amazon and Walmart pose public health risk, FDA warns
-
Neighborhood conditions linked to childhood cancer survivors' long-term health
-
Phenobarbital shows no clear advantage over diazepam for alcohol withdrawal, large study finds